Prodia Widyahusada Tbk PT operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Prodia Widyahusada Tbk PT with three other
pharmaceutical manufacturers in Asia:
Hang Tai Yue Group Holdings Ltd
of Hong Kong
sales of 471.48 million Hong Kong Dollars [US$60.66 million]
of which 77%
was Mobile Internet Cultural Business),
Medical & Biological Laboratories Company Limited
(7.07 billion Japanese Yen [US$63.51 million]
of which 99%
was Reagent business), and
Dr. Lal PathLabs Ltd
based in India
(10.57 billion Indian Rupees [US$147.65 million]
of which 100%
Prodia Widyahusada Tbk PT reported sales of 1.60 trillion Indonesian Rupiahs (US$116.94 million)
December of 2018.
increase of 9.1%
versus 2017, when the company's sales were 1.47 trillion Indonesian Rupiahs.
Sales at Prodia Widyahusada Tbk PT have increased during each of the previous five years
(and since 2013, sales have increased a total of 60%).